Verified IDGLUEMonte Rosa Therapeutics, Inc.Pharmaceuticals & BiotechFollowSaveShareRevenue · 12m$70.3MAsk IntelSource-backedSuggested question →How much of Monte Rosa Therapeutics's business depends on government, and what could change it?Ask your own question→Company page →Records as of 17 Nov 2026.